These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 10822211

  • 1. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison.
    Spence JD, Huff M, Barnett PA.
    Can J Clin Pharmacol; 2000; 7(1):32-7. PubMed ID: 10822211
    [Abstract] [Full Text] [Related]

  • 2. [Possibilities of using indices of vascular wall function as markers of negative metabolic effects of treatment with thiazide diuretics in patients with essential hypertension].
    Semenkin AA.
    Ter Arkh; 2007; 79(4):31-8. PubMed ID: 17564015
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy.
    Krum H, Skiba M, Gilbert RE.
    Diabet Med; 2003 Sep; 20(9):708-12. PubMed ID: 12925048
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).
    Lindholm LH, Persson M, Alaupovic P, Carlberg B, Svensson A, Samuelsson O.
    J Hypertens; 2003 Aug; 21(8):1563-74. PubMed ID: 12872052
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 9. Influence of combination of captopril and hydrochlorothiazide on plasma lipids, lipoproteins and apolipoproteins in primary hypertension.
    Lacourcière Y, Gagné C.
    J Hum Hypertens; 1993 Apr; 7(2):149-52. PubMed ID: 8510087
    [Abstract] [Full Text] [Related]

  • 10. Placebo-controlled comparison of the effects of nebivolol and low-dose hydrochlorothiazide as monotherapies and in combination on blood pressure and lipid profile in hypertensive patients.
    Lacourcière Y, Arnott W.
    J Hum Hypertens; 1994 Apr; 8(4):283-8. PubMed ID: 8021909
    [Abstract] [Full Text] [Related]

  • 11. Step-one antihypertensive therapy: a comparison of a centrally acting agent and a diuretic.
    McCarron DA.
    J Cardiovasc Pharmacol; 1984 Apr; 6 Suppl 5():S853-8. PubMed ID: 6084139
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P, Eide I, Foss OP, Helgeland A, Hjermann I, Holme I, Kjeldsen SE, Lund-Larsen PG.
    J Cardiovasc Pharmacol; 1982 Apr; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [Abstract] [Full Text] [Related]

  • 13. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P, de Courten M, Ferrari P, Böhlen L.
    J Cardiovasc Pharmacol; 1993 Apr; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [Abstract] [Full Text] [Related]

  • 14. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease.
    Ceylan K, Topal C, Erkoc R, Sayarlioglu H, Can S, Yilmaz Y, Dogan E, Algun E, Gonulalan H.
    Ann Pharmacother; 2005 Jun; 39(6):1034-8. PubMed ID: 15840731
    [Abstract] [Full Text] [Related]

  • 15. A comparison of initial treatment with losartan/HCTZ versus losartan monotherapy in chinese patients with mild to moderate essential hypertension.
    Li Y, Liu G, Jiang B, Gao R, Chen L, Su L, Li J.
    Int J Clin Pract; 2003 Oct; 57(8):673-7. PubMed ID: 14627176
    [Abstract] [Full Text] [Related]

  • 16. Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands.
    Hoogerbrugge N, de Groot E, de Heide LH, de Ridder MA, Birkenhägeri JC, Stijnen T, Jansen H.
    Neth J Med; 2002 Oct; 60(9):354-61. PubMed ID: 12572707
    [Abstract] [Full Text] [Related]

  • 17. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL, Glazer R, Weinberger M, Alvarado R, Huang J, Graff A.
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [Abstract] [Full Text] [Related]

  • 18. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
    Villamil A, Chrysant SG, Calhoun D, Schober B, Hsu H, Matrisciano-Dimichino L, Zhang J.
    J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
    [Abstract] [Full Text] [Related]

  • 19. Hyperlipidemia of diuretic therapy.
    Ames R.
    Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.